Josep F Nomdedeu Guinot
YOU?
Author Swipe
View article: Establishing contemporary benchmarks for Acute Myeloid Leukemia outcomes and measurable residual disease: Real-world data utilization from the ELN-david MRD international working group
Establishing contemporary benchmarks for Acute Myeloid Leukemia outcomes and measurable residual disease: Real-world data utilization from the ELN-david MRD international working group Open
Background The treatment landscape of acute myeloid leukemia (AML) is rapidly evolving due to advances in novel targeted agents, lower-intensity treatments, and allogeneic stem cell transplantation. Simultaneously, technologic advances are…